Figure 2.

Graphic representation of the study plan of the ongoing TRIAL V (Tumor necrosis factor blockade with Remicade In Active Lupus nephritis class V) randomized placebo-controlled clinical trial. More details can be found at [76]. ACE, angiotensin-converting enzyme; WHO, World Health Organization.

Aringer and Smolen Arthritis Research & Therapy 2008 10:202   doi:10.1186/ar2341
Download authors' original image